甲状腺球蛋白自身抗体对免疫计量法、液相色谱串联质谱法和放射免疫法测定甲状腺球蛋白水平的影响
研究比较免疫计量法(IMA)、液相色谱串联质谱法(MS)和放射免疫法(RIA)在甲状腺球蛋白抗体(TgAb)阴性和阳性患者中测定血清甲状腺球蛋白(Tg)的表现。TgAb阳性时所有方法测得的Tg均低于各自TgAb阴性组,约50%的TgAb阳性分化型甲状腺癌(DTC)患者IMA或MS未检出Tg(RIA为6%)。作者结论认为方法间Tg变异要求TgAb阴性DTC患者监测时保持方法连续性,TgAb存在及浓度对三种方法测定的Tg均有降低效应,TgAb趋势可作为DTC肿瘤标志物的替代指标。
要点
- TgAb阴性时三种方法均能检出DTC和甲亢患者血清Tg,但方法间变异系数>30%。
- TgAb阳性时所有方法测得的Tg均低于各自TgAb阴性组。
- 约50%的TgAb阳性DTC患者IMA或MS未检出Tg,RIA未检出者为6%。
核心结论
- 方法间Tg变异要求TgAb阴性DTC患者监测Tg趋势时保持方法连续性。
- TgAb的存在和浓度似乎对IMA、MS和RIA测定的血清Tg均有降低效应。
- TgAb存在时Tg测定的可靠性常不确定,同一方法测定的TgAb趋势可能是有用的DTC肿瘤标志物替代指标。
研究设计与样本
- 研究使用IMA、MS和RIA三种方法测定TgAb阴性和TgAb阳性患者的血清Tg,对象为预期可检出Tg的远处转移性DTC或甲亢(HY)患者。
主要发现
- TgAb阴性时,所有方法均检出全部DTC和HY患者的血清Tg,并对进展性远处转移DTC患者报告了合适的Tg趋势和治疗反应,但方法间变异系数>30%。
- TgAb阳性时,所有方法报告的DTC组和HY组血清Tg水平均低于各自对应的TgAb阴性组。
- 约50%的TgAb阳性DTC患者IMA或MS未检出Tg,6%经RIA未检出Tg;5%的TgAb阳性HY患者IMA或MS也未检出Tg。
- TgAb阳性HY患者组中所有方法均观察到log TgAb与log Tg呈负相关,提示存在TgAb相关的血清Tg降低效应。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Serum thyroglobulin (Tg) measured by immunometric assay (IMA) is prone to underestimation due to Tg autoantibody (TgAb) interference, often prompting reflex Tg measurement by liquid chromatography/tandem mass spectrometry (MS) or radioimmunoassay (RIA). OBJECTIVE: IMA, MS, and RIA methodologies were used to measure serum Tg in TgAb-negative (TgAb-) and TgAb-positive (TgAb+) patients with either distant metastatic differentiated thyroid cancer (DTC) or hyperthyroidism (HY)-patients in whom a detectable serum Tg would be expected. RESULTS: When TgAb was absent, all methodologies detected Tg in the sera of all DTC and HY patients and reported appropriate Tg trends and treatment responses for DTC patients with progressive distant metastatic disease, albeit with high between-method variability (> 30% coefficient of variability). When TgAb was present, all methodologies reported lower serum Tg levels for both DTC and HY groups vs their respective TgAb- group. No Tg was detected by IMA or MS in ∼50% TgAb+ DTC patients (6% had no Tg detected by RIA). Surprisingly, 5% of TgAb+ HY patients also had no Tg detected by IMA or MS. The inverse log TgAb/log Tg correlations seen for the TgAb+ HY patient group with all methods suggested the presence of a TgAb-associated serum Tg-lowering effect. CONCLUSION: (i) Between-method Tg variability necessitates method continuity when monitoring the Tg trends of TgAb- DTC patients. (ii) The presence and concentration of TgAb appeared to have a lowering effect on serum Tg measured by all methodologies (IMA, MS, and RIA). (iii) Since the reliability of Tg measured in the presence of TgAb is often uncertain, the TgAb trend (measured by the same method) may be a useful surrogate DTC tumor marker.
引用
- Petrovic I, LoPresti J, Fatemi S, et al. Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA. J Clin Endocrinol Metab. 2024. PMID: 38686504. doi:10.1210/clinem/dgae286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。